A phenome-wide association and Mendelian Randomisation study of polygenic risk for depression in UK Biobank.
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Author
Shen, XueyiHoward, David M
Adams, Mark J
Hill, W David
Clarke, Toni-Kim
Deary, Ian J
Whalley, Heather C
McIntosh, Andrew M
Journal title
Nature communicationsDate Published
2020-05-08Publication Volume
11Publication Issue
1Publication Begin page
2301
Metadata
Show full item recordAbstract
Depression is a leading cause of worldwide disability but there remains considerable uncertainty regarding its neural and behavioural associations. Here, using non-overlapping Psychiatric Genomics Consortium (PGC) datasets as a reference, we estimate polygenic risk scores for depression (depression-PRS) in a discovery (N = 10,674) and replication (N = 11,214) imaging sample from UK Biobank. We report 77 traits that are significantly associated with depression-PRS, in both discovery and replication analyses. Mendelian Randomisation analysis supports a potential causal effect of liability to depression on brain white matter microstructure (β: 0.125 to 0.868, p < 0.043). Several behavioural traits are also associated with depression-PRS (β: 0.014 to 0.180, p: 0.049 to 1.28 × 10) and we find a significant and positive interaction between depression-PRS and adverse environmental exposures on mental health outcomes. This study reveals replicable associations between depression-PRS and white matter microstructure. Our results indicate that white matter microstructure differences may be a causal consequence of liability to depression.Citation
Shen X, Howard DM, Adams MJ, Hill WD, Clarke TK; Major Depressive Disorder Working Group of the Psychiatric Genomics Consortium; Deary IJ, Whalley HC, McIntosh AM. A phenome-wide association and Mendelian Randomisation study of polygenic risk for depression in UK Biobank. Nat Commun. 2020 May 8;11(1):2301. doi: 10.1038/s41467-020-16022-0. PMID: 32385265; PMCID: PMC7210889.DOI
10.1038/s41467-020-16022-0ae974a485f413a2113503eed53cd6c53
10.1038/s41467-020-16022-0
Scopus Count
Collections
The following license files are associated with this item:
- Creative Commons
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivatives 4.0 International
Related articles
- A Phenome-wide Association and Mendelian Randomization Study for Alzheimer's Disease: A Prospective Cohort Study of 502,493 Participants From the UK Biobank.
- Authors: Chen SD, Zhang W, Li YZ, Yang L, Huang YY, Deng YT, Wu BS, Suckling J, Rolls ET, Feng JF, Cheng W, Dong Q, Yu JT
- Issue date: 2023 May 1
- Identifying the potential causal role of insomnia symptoms on 11,409 health-related outcomes: a phenome-wide Mendelian randomisation analysis in UK Biobank.
- Authors: Gibson MJ, Lawlor DA, Millard LAC
- Issue date: 2023 Apr 3
- DNA methylome-wide association study of genetic risk for depression implicates antigen processing and immune responses.
- Authors: Shen X, Caramaschi D, Adams MJ, Walker RM, Min JL, Kwong A, Hemani G, Genetics of DNA Methylation Consortium, Barbu MC, Whalley HC, Harris SE, Deary IJ, Morris SW, Cox SR, Relton CL, Marioni RE, Evans KL, McIntosh AM
- Issue date: 2022 Mar 31
- Evidence for causal effects of lifetime smoking on risk for depression and schizophrenia: a Mendelian randomisation study.
- Authors: Wootton RE, Richmond RC, Stuijfzand BG, Lawn RB, Sallis HM, Taylor GMJ, Hemani G, Jones HJ, Zammit S, Davey Smith G, Munafò MR
- Issue date: 2020 Oct
- Cannabis use, depression and self-harm: phenotypic and genetic relationships.
- Authors: Hodgson K, Coleman JRI, Hagenaars SP, Purves KL, Glanville K, Choi SW, O'Reilly P, Breen G, Major Depressive Disorder Working Group of the Psychiatric Genomics Consortium, Lewis CM
- Issue date: 2020 Mar